EDAP Announces Record Q4 US Focal One Placements
January 05, 2023 08:00 ET
|
EDAP TMS S.A.
Company preliminarily reports nine Focal One Placements in the U.S., including seven sales LYON, France, January 5, 2023 -- EDAP TMS SA (NASDAQ: EDAP) (the “Company”), the global leader in...
EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary
December 06, 2022 08:00 ET
|
EDAP TMS S.A.
LYON, France, December 6, 2022 -- EDAP TMS SA (NASDAQ: EDAP) (the “Company”), the global leader in robotic energy-based therapies, announced today that the Company has hired medical capital equipment...
EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis
November 30, 2022 16:01 ET
|
EDAP TMS S.A.
Study to begin enrolling patients in Q2 2023 Endometriosis represents significant expansion opportunity for Focal One LYON, France, November 30, 2022 -- EDAP TMS SA (Nasdaq: EDAP)...
EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference
November 21, 2022 08:00 ET
|
EDAP TMS S.A.
LYON, France, November 21, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today that Marc Oczachowski, Chief Executive Officer, is...
EDAP Reports Third Quarter 2022 Results
November 16, 2022 16:35 ET
|
EDAP TMS S.A.
Generated Q3 2022 total revenue of approximately EUR 12.2 million (USD 12.3 million), an increase of 29.7 % as compared to EUR 9.4 million (USD 11.1 million) for Q3 2021; nine-month year-to-date...
EDAP TMS SA to Announce Third Quarter 2022 Financial Results on Wednesday, November 16th, 2022
November 02, 2022 08:00 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, November 17th at 8:30 am EDT LYON, France, November 2, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...
EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY23
November 01, 2022 17:22 ET
|
EDAP TMS S.A.
Final rule significantly raises Medicare reimbursement to U.S. hospitals performing a Focal One HIFU prostate ablation procedure LYON, France, November 1, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the...
EDAP TMS Hosting Urology Expert Panel and Live Focal One® Technology Demonstration
September 26, 2022 08:00 ET
|
EDAP TMS S.A.
September 29, 2022 @ 8 AM ETLangham Hotel, NYC LYON, France, September 26, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic therapeutic ultrasound, announced today it...
EDAP Announces Pricing of Public Offering of American Depositary Shares
September 22, 2022 20:54 ET
|
EDAP TMS S.A.
LYON, France, September 22, 2022 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced that the price of its public offering of its American...
EDAP Announces Proposed Public Offering of American Depositary Shares
September 22, 2022 16:01 ET
|
EDAP TMS S.A.
LYON, France, September 22, 2022 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today that it has commenced a public offering of its...